CEREZYME Side Effects

6625781-8 | Abdominal Pain, Breast Cancer In Situ, Joint Dislocation, Pain In Extremity
on Feb 22, 2010 Female patient from UNITED STATES , 48 years of age, weighting 158.3 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), breast cancer in situ, joint dislocation, pain in extremity. Cerezyme dosage: 4000 U, Q2w, Intravenous. Patient was hospitalized.

6622139-2 | Pregnancy, Thrombocytopenia
Patient was taking Cerezyme (View Usage). Patient had the following side effects: pregnancy (What is pregnancy?), thrombocytopenia on Feb 22, 2010 from UKRAINE Additional patient health information: Female patient , 30 years of age, weighting 149.9 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: See Image.

6622007-6 | Chronic Lymphocytic Leukaemia, Respiratory Distress, Septic Shock, Thyroid Cancer
Adverse event was reported on Feb 24, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , 76 years of age, weighting 193.3 lb, After Cerezyme was administered, patient had the following side effects: chronic lymphocytic leukaemia, respiratory distress, septic shock, thyroid cancer (What is thyroid cancer?). Patient was hospitalized.

6618635-4 | Bronchial Disorder
on Feb 26, 2010 Male patient from UNITED STATES , weighting 205.0 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: bronchial disorder. Cerezyme dosage: 3000 U, Qw. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), CIALIS (View Cialis Review and Cialis Label ).


6618125-9 | Parkinson's Disease
on Feb 26, 2010 Female patient from UNITED STATES , weighting 185.2 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: parkinson's disease (What is parkinson's disease?). Cerezyme dosage: 3000 U, Q2w.

6611678-6 | Bone Pain, Eye Infection, Fibula Fracture, Herpes Virus Infection, Intervertebral Disc Injury, Myalgia, Neuralgia, Spinal Compression Fracture, Tibia Fracture
Patient was taking Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: bone pain, eye infection (What is eye infection?), fibula fracture, herpes virus infection, intervertebral disc injury, myalgia, neuralgia, spinal compression fracture, tibia fracture on Feb 09, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 181.0 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 3600 U, Q2w, Intravenous. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), DETROL LA (View Detrol La Review and Detrol La Label ), CLARITIN (View Claritin Review and Claritin Label ), SINGULAIR (View Singulair Review and Singulair Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), REMERON (View Remeron Review and Remeron Label ), ROZEREM (View Rozerem Review and Rozerem Label ), ALBUTEROL (SALBUTAMOL SULFATE) (View Albuterol (salbutamol Sulfate) Review and Albuterol (salbutamol Sulfate) Label ). Patient was hospitalized.

6610873-X | Chest Discomfort, Coagulopathy, Disease Progression, Febrile Convulsion, Gaucher's Disease, Haemoglobin Decreased, Hepatosplenomegaly, Hypersensitivity, Lower Limb Fracture
Adverse event was reported on Feb 16, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 1200 U) was diagnosed with gaucher's disease and. Location: EGYPT , child 10 years of age, weighting 55.12 lb, Patient experienced the following unwanted or unexpected effects: chest discomfort, coagulopathy, disease progression, febrile convulsion, gaucher's disease, haemoglobin decreased, hepatosplenomegaly, hypersensitivity, lower limb fracture. During the same period patient was treated with CALCIUM (ASCORBIC ACID) (View Calcium (ascorbic Acid) Review and Calcium (ascorbic Acid) Label ), BIPHOSPHONATE (View Biphosphonate Review and Biphosphonate Label ).

6600365-6 | Acidosis, Asthma, Bronchopneumonia, Bronchospasm, Candida Sepsis, Cardiac Arrest, Haemorrhage, Infusion Site Haemorrhage, Thrombocytopenia
on Feb 05, 2010 Male patient from MEXICO , child 2 years of age, weighting 30.86 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: acidosis, asthma (What is asthma?), bronchopneumonia, bronchospasm, candida sepsis, cardiac arrest (What is cardiac arrest?), haemorrhage, infusion site haemorrhage, thrombocytopenia. Cerezyme dosage: 60 U/kg, Intravenous. Patient was hospitalized.

6599406-4 | Blood Pressure Decreased, Transient Ischaemic Attack
on Feb 09, 2010 Male patient from UNITED STATES , 64 years of age, weighting 116.8 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: blood pressure decreased, transient ischaemic attack. Cerezyme dosage: 3200 U, 2qw, Intravenous. Patient was hospitalized.

6599310-1 | Multiple Sclerosis
Patient was taking Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: multiple sclerosis (What is multiple sclerosis?) on Feb 08, 2010 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 112.4 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 70 U/kg, Q2w, Intravenous. Patient was hospitalized.

6597157-3 | Acute Leukaemia
Adverse event was reported on Feb 04, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 60 U/kg, Intravenous; 45 U/kg, Q2w, Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , 64 years of age, weighting 197.1 lb, Patient had the following side effects: acute leukaemia. Patient was hospitalized.

6596848-8 | Metastatic Neoplasm
on Jan 26, 2010 Male patient from UNITED STATES , 94 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: metastatic neoplasm. Cerezyme dosage: 40 U/kg, Q2w, Intravenous.

6596842-7 | Economic Problem, Road Traffic Accident
on Jan 24, 2010 Female patient from UNITED STATES , 83 years of age, weighting 93.92 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: economic problem, road traffic accident. Cerezyme dosage: 500 U, Intravenous. During the same period patient was treated with BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ).

6596839-7 | Fall, Headache, Hypophagia, Limb Injury, Loss Of Consciousness, Mouth Injury, Nail Injury, Oral Infection, Skin Laceration
Patient was taking Cerezyme (View Usage). Patient had the following side effects: fall (What is fall?), headache (What is headache?), hypophagia, limb injury, loss of consciousness, mouth injury, nail injury, oral infection, skin laceration on Jan 27, 2010 from UNITED STATES Additional patient health information: Female patient , 17 years of age, weighting 127.0 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 2400 U, Q2w, Intravenous.

6595155-7 | Coronary Artery Disease, Osteonecrosis, Waldenstrom's Macroglobulinaemia
Adverse event was reported on Feb 05, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 3600 U, Q2w,) was diagnosed with gaucher's disease and. Location: UNITED STATES , 81 years of age, weighting 176.4 lb, After Cerezyme was administered, patient had the following side effects: coronary artery disease (What is coronary artery disease?), osteonecrosis (What is osteonecrosis?), waldenstrom's macroglobulinaemia.

6593745-9 | Femoral Neck Fracture
on Feb 18, 2010 Female patient from CANADA , weighting 359.1 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: femoral neck fracture. Cerezyme dosage: 51.6 U/kg, Unk. During the same period patient was treated with ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), NICOTINE (Unk) (View Nicotine Review and Nicotine Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ), VITAMIN D AND CALCIUM (Unk) (View Vitamin D And Calcium Review and Vitamin D And Calcium Label ), ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ), TIOTROPIUM (Unk) (View Tiotropium Review and Tiotropium Label ), FOSAMAX (Unk) (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6592998-0 | Nervous System Disorder, Retinal Artery Occlusion
on Feb 05, 2010 Male patient from ITALY , 26 years of age, weighting 143.3 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: nervous system disorder, retinal artery occlusion. Cerezyme dosage: 30 U/kg, Q4w, Intravenous. During the same period patient was treated with XERISTAR (View Xeristar Review and Xeristar Label ).

6592919-0 | Dyspnoea, Osteonecrosis, Thoracic Vertebral Fracture
Patient was taking Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: dyspnoea, osteonecrosis (What is osteonecrosis?), thoracic vertebral fracture on Feb 04, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 51 years of age, weighting 110.2 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 1800 U, Q4w, Intravenous. During the same period patient was treated with PENICILLIN (BENZYLPENICILLIN) (View Penicillin (benzylpenicillin) Review and Penicillin (benzylpenicillin) Label ), CALCICHEW (CALCIUM CARBONATE) (View Calcichew (calcium Carbonate) Review and Calcichew (calcium Carbonate) Label ).

6592918-9 | Cardiac Failure, Hypertension, Myocardial Infarction, Transient Ischaemic Attack
Adverse event was reported on Feb 01, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 4400 U, Intravenous) was diagnosed with gaucher's disease and. Location: GERMANY , 63 years of age, weighting 213.8 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure, hypertension, myocardial infarction, transient ischaemic attack. During the same period patient was treated with ZAVESCA (View Zavesca Review and Zavesca Label ), LOSARTAN (LOSARTAN) (View Losartan (losartan) Review and Losartan (losartan) Label ), BISOPROLOL WITH HCT (BISOPROLOL WITH HCT) (View Bisoprolol With Hct (bisoprolol With Hct) Review and Bisoprolol With Hct (bisoprolol With Hct) Label ), CALCIUM (CALCIUM CARBONATE) (View Calcium (calcium Carbonate) Review and Calcium (calcium Carbonate) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ALENDRONAT (ALENDRONATE SODIUM) (View Alendronat (alendronate Sodium) Review and Alendronat (alendronate Sodium) Label ).

6582924-2 | Disease Progression, Normal Pressure Hydrocephalus, Pulmonary Hypertension, Renal Failure
on Jan 21, 2010 Female patient from FRANCE , 81 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: disease progression, normal pressure hydrocephalus, pulmonary hypertension (What is pulmonary hypertension?), renal failure. Cerezyme dosage: .

6582919-9 | Haemoptysis, Lung Infection, Sepsis
on Jan 21, 2010 Female patient from TURKEY , weighting 22.05 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: haemoptysis, lung infection, sepsis (What is sepsis?). Cerezyme dosage: .

6582907-2 | Chronic Obstructive Pulmonary Disease, Femoral Neck Fracture, Pneumonia
Patient was taking Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease, femoral neck fracture, pneumonia (What is pneumonia?) on Feb 10, 2010 from CANADA Additional patient health information: Female patient , weighting 359.1 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 51.6 U/kg, Unk. During the same period patient was treated with ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), NICOTINE (Unk) (View Nicotine Review and Nicotine Label ), SPIRIVA (Unk) (View Spiriva Review and Spiriva Label ), VITAMIN D AND CALCIUM (Unk) (View Vitamin D And Calcium Review and Vitamin D And Calcium Label ), ALBUTEROL (Unk) (View Albuterol Review and Albuterol Label ), TIOTROPIUM (Unk) (View Tiotropium Review and Tiotropium Label ), FOSAMAX (Unk) (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6580136-X | Complication Of Pregnancy, In Vitro Fertilisation, Thrombocytopenia
Adverse event was reported on Jan 22, 2010 by a Female patient taking Cerezyme (View Usage) (Dosage: See Image) was diagnosed with gaucher's disease and. Location: UKRAINE , 30 years of age, weighting 149.9 lb, Patient had the following side effects: complication of pregnancy, in vitro fertilisation, thrombocytopenia.

6578821-9 | Acute Respiratory Failure, Bronchitis, Condition Aggravated, Disease Complication, Epilepsy, Gastroenteritis, Neurological Symptom, Pneumonia
on Jan 19, 2010 Male patient from JAPAN , child 6 years of age, weighting 35.27 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: acute respiratory failure, bronchitis (What is bronchitis?), condition aggravated, disease complication, epilepsy (What is epilepsy?), gastroenteritis (What is gastroenteritis?), neurological symptom, pneumonia (What is pneumonia?). Cerezyme dosage: 68 U/kg, Q2w, Intravenous.

6578773-1 | Antibody Test Positive, Blood Alkaline Phosphatase Increased, Erythema, Eye Rolling, Flushing, Haemoglobin Decreased, Hypotension, Infusion Related Reaction, Platelet Count Decreased
on Jan 19, 2010 Male patient from FRANCE , 63 years of age, weighting 198.4 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: antibody test positive, blood alkaline phosphatase increased, erythema, eye rolling, flushing, haemoglobin decreased, hypotension, infusion related reaction, platelet count decreased. Cerezyme dosage: 2000 U, Intravenous. During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6576717-X | Abortion Induced, Fatigue, Platelet Count Decreased, Pregnancy, Splenomegaly
Patient was taking Cerezyme (View Usage). Patient had the following side effects: abortion induced, fatigue, platelet count decreased, pregnancy (What is pregnancy?), splenomegaly on Jan 29, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 110.2 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 45 U/kg, Q2w.

6574107-7 | Adverse Event, Anaemia, Blood Erythropoietin Increased, Bone Disorder, Exfoliative Rash, Myelofibrosis, Post Procedural Infection, Pruritus
Adverse event was reported on Jan 18, 2010 by a Female patient taking Cerezyme (View Usage) (Dosage: 4600 U, Qw, Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , 49 years of age, weighting 163.1 lb, After Cerezyme was administered, patient had the following side effects: adverse event, anaemia, blood erythropoietin increased, bone disorder, exfoliative rash, myelofibrosis, post procedural infection, pruritus. Patient was hospitalized.

6568553-5 | Dyspnoea, Epilepsy, Lung Disorder
on Jan 17, 2010 Male patient from RUSSIAN FEDERATION , child 5 years of age, weighting 38.58 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, epilepsy (What is epilepsy?), lung disorder. Cerezyme dosage: 1800 U, Q2w, Intravenous. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), CONVULEX (VALPROIC ACID) (View Convulex (valproic Acid) Review and Convulex (valproic Acid) Label ). Patient was hospitalized and became disabled.

6552934-X | Bone Density Decreased, Fall, Ligament Injury, Tibia Fracture
on Jan 11, 2010 Male patient from CHINA , 38 years of age, weighting 132.3 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: bone density decreased, fall (What is fall?), ligament injury, tibia fracture. Cerezyme dosage: . Patient was hospitalized.

6552436-0 | Femur Fracture, Impaired Healing, Osteonecrosis, Stress Fracture
Patient was taking Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: femur fracture, impaired healing, osteonecrosis (What is osteonecrosis?), stress fracture on Jan 15, 2010 from UNITED STATES Additional patient health information: Male patient , child 7 years of age, weighting 39.90 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 2200 U, Q2w, Intravenous.

6552435-9 |
Adverse event was reported on Jan 06, 2010 by a Male patient taking Cerezyme (View Usage) (Dosage: 2000 U, Q2w, Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , 63 years of age, weighting 145.5 lb, .

6552434-7 | Bone Marrow Transplant, Myelodysplastic Syndrome, Myelofibrosis
on Jan 12, 2010 Female patient from UNITED STATES , 51 years of age, weighting 156.5 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: bone marrow transplant (What is bone marrow transplant?), myelodysplastic syndrome, myelofibrosis. Cerezyme dosage: 60 U/kg, Q2w, Intravenous. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), PROZAC (View Prozac Review and Prozac Label ), DYAZIDE (View Dyazide Review and Dyazide Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ). Patient was hospitalized.

6551823-4 | Flushing, Hypotension
on Jan 06, 2010 Male patient from FRANCE , 63 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: flushing, hypotension. Cerezyme dosage: Unk, Intravenous. Patient was hospitalized.

6551704-6 | Oesophageal Carcinoma
Patient was taking Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal carcinoma on Jan 05, 2010 from SWEDEN Additional patient health information: Male patient , 50 years of age, weighting 141.1 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 4000 U, Q2w, Intravenous. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DUROFERON DEPOT (DUROFERON DEPOT) (View Duroferon Depot (duroferon Depot) Review and Duroferon Depot (duroferon Depot) Label ), LASIX RETARD (LASIX RETARD) (View Lasix Retard (lasix Retard) Review and Lasix Retard (lasix Retard) Label ), BENZYLPENICILLIN (BENZYLPENICILLIN) (View Benzylpenicillin (benzylpenicillin) Review and Benzylpenicillin (benzylpenicillin) Label ), LAKTULOSDR (LAKTULOSDR) (View Laktulosdr (laktulosdr) Review and Laktulosdr (laktulosdr) Label ).

6551166-9 | Acute Myeloid Leukaemia Recurrent, Anal Neoplasm, Anorectal Cellulitis, Blood Creatine Phosphokinase Increased, Blood Urea Increased, Csf Culture Positive, Cytomegalovirus Infection, Haemorrhage, Septic Shock
Adverse event was reported on Jan 07, 2010 by a Female patient taking Cerezyme (View Usage) (Dosage: 2200 U, Q2w, Intravenous) was diagnosed with gaucher's disease and. Location: FRANCE , 69 years of age, Patient had the following side effects: acute myeloid leukaemia recurrent, anal neoplasm, anorectal cellulitis, blood creatine phosphokinase increased, blood urea increased, csf culture positive, cytomegalovirus infection (What is cytomegalovirus infection?), haemorrhage, septic shock. During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ORACILLIN (PHENOXYMETHYLPENICILLIN POTASSIUM) (View Oracillin (phenoxymethylpenicillin Potassium) Review and Oracillin (phenoxymethylpenicillin Potassium) Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), EXJADE (View Exjade Review and Exjade Label ), GINKOR FORT (GINKGO BILOBA, HEPTAMINOL HYDROCHLORIDE, TROXERUTIN) (View Ginkor Fort (ginkgo Biloba, Heptaminol Hydrochloride, Troxerutin) Review and Ginkor Fort (ginkgo Biloba, Heptaminol Hydrochloride, Troxerutin) Label ). Patient was hospitalized.

6551165-7 | Haemodialysis, Nephropathy, Oedema Peripheral, Renal Failure Chronic
on Jan 13, 2010 Male patient from SERBIA , 64 years of age, weighting 163.1 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: haemodialysis, nephropathy, oedema peripheral, renal failure chronic. Cerezyme dosage: 30 Mg/kg, Q2w, Intravenous. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ). Patient was hospitalized.

6544522-6 | Anaemia, Pregnancy, Thrombocytopenia
on Jan 03, 2010 Female patient from ISRAEL , 24 years of age, weighting 112.4 lb, was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, pregnancy (What is pregnancy?), thrombocytopenia. Cerezyme dosage: 30 U/kg, Q2w, Intravenous.

6537003-7 | Chest Discomfort, Choking, Coagulopathy, Disease Progression, Febrile Convulsion, Gaucher's Disease, Haemoglobin Decreased
Patient was taking Cerezyme (View Usage). Patient had the following side effects: chest discomfort, choking (What is choking?), coagulopathy, disease progression, febrile convulsion, gaucher's disease, haemoglobin decreased on Dec 24, 2009 from EGYPT Additional patient health information: Male patient , child 10 years of age, weighting 55.12 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 1200 U. During the same period patient was treated with CALCIUM (ASCORBIC ACID) (View Calcium (ascorbic Acid) Review and Calcium (ascorbic Acid) Label ), BIPHOSPHONATE (BIPHOSPHONATE) (View Biphosphonate (biphosphonate) Review and Biphosphonate (biphosphonate) Label ).

6537002-5 | Anaemia, Pregnancy, Thrombocytopenia
Adverse event was reported on Dec 23, 2009 by a Female patient taking Cerezyme (View Usage) (Dosage: Intravenous) . Location: ISRAEL , 24 years of age, weighting 116.8 lb, After Cerezyme was administered, patient had the following side effects: anaemia, pregnancy (What is pregnancy?), thrombocytopenia.

6536907-9 | Flushing, Hypotension, Infusion Related Reaction
on Dec 22, 2009 Male patient from FRANCE , 64 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: flushing, hypotension, infusion related reaction. Cerezyme dosage: Intravenous. Patient was hospitalized.

6536816-5 | Platelet Count Decreased
on Dec 28, 2009 Female patient from UNITED STATES , 39 years of age, weighting 132.9 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: platelet count decreased. Cerezyme dosage: 3540 U, Q2w, Intravenous.

6536815-3 | Aortic Dilatation, Aortic Valve Incompetence, Deafness Unilateral, Ruptured Cerebral Aneurysm
Patient was taking Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: aortic dilatation, aortic valve incompetence, deafness unilateral, ruptured cerebral aneurysm on Jan 04, 2010 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 213.8 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 2800 U, Q2w, Intravenous, 3000 U, Q2w, Iv. Patient was hospitalized.

6535227-6 | Tibia Fracture
Adverse event was reported on Dec 28, 2009 by a Male patient taking Cerezyme (View Usage) (Dosage: 6000 U, Q2w, Intravenous) was diagnosed with gaucher's disease and. Location: UNITED STATES , 55 years of age, Patient experienced the following unwanted or unexpected effects: tibia fracture. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), HYDROCODONE (HYDROCODONE) (View Hydrocodone (hydrocodone) Review and Hydrocodone (hydrocodone) Label ), AMBIEN (View Ambien Review and Ambien Label ). Patient was hospitalized.

6535224-0 | Back Pain, Chest Pain
on Dec 23, 2009 Female patient from UNITED STATES , 25 years of age, weighting 90.39 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient had the following side effects: back pain (What is back pain?), chest pain (What is chest pain?). Cerezyme dosage: 1200 U, Q2w, Intravenous. Patient was hospitalized.

6526411-6 | Arthritis, Blood Pressure Increased, Breast Cancer Female, Chest Pain, Dysarthria, Erythema, Inappropriate Antidiuretic Hormone Secretion
on Dec 14, 2009 Female patient from UNITED STATES , 71 years of age, weighting 181.7 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: arthritis (What is arthritis?), blood pressure increased, breast cancer female, chest pain (What is chest pain?), dysarthria, erythema, inappropriate antidiuretic hormone secretion. Cerezyme dosage: 60 U/kg, Q3w, Intravenous. Patient was hospitalized.

6526378-0 | Aortic Dilatation, Aortic Valve Incompetence, Deafness Unilateral, Loss Of Consciousness, Procedural Hypotension, Ruptured Cerebral Aneurysm, Vascular Occlusion
Patient was taking Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: aortic dilatation, aortic valve incompetence, deafness unilateral, loss of consciousness, procedural hypotension, ruptured cerebral aneurysm, vascular occlusion on Dec 21, 2009 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 213.8 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 2800 U, Q2w, Intravenous; 3000 U, Q2w, Intravenous. Patient was hospitalized.

6525763-0 | Viral Upper Respiratory Tract Infection
Adverse event was reported on Dec 14, 2009 by a Male patient taking Cerezyme (View Usage) (Dosage: 60 U/kg, Q2w, Intravenous) was diagnosed with gaucher's disease and. Location: GREECE , 13 years of age, Patient had the following side effects: viral upper respiratory tract infection.

6523624-4 | Dyspnoea, Epilepsy, Lung Disorder
on Dec 15, 2009 Male patient from RUSSIAN FEDERATION , child 5 years of age, weighting 38.58 lb, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). After Cerezyme was administered, patient had the following side effects: dyspnoea, epilepsy (What is epilepsy?), lung disorder. Cerezyme dosage: 1800 U, Q2w, Intravenous. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), CONVULEX (VALPROIC ACID) (View Convulex (valproic Acid) Review and Convulex (valproic Acid) Label ). Patient was hospitalized and became disabled.

6523183-6 | Septic Shock
on Dec 16, 2009 Female patient from FRANCE , 69 years of age, was diagnosed with gaucher's disease and was treated with Cerezyme (View Usage). Patient experienced the following unwanted or unexpected effects: septic shock. Cerezyme dosage: Intravenous. Patient was hospitalized.

6517810-7 | Abdominal Discomfort, Haemoglobin Decreased, Infection, Malaise, Pyrexia, Sepsis, Urinary Tract Infection
Patient was taking Cerezyme (View Usage). Patient had the following side effects: abdominal discomfort, haemoglobin decreased, infection (What is infection?), malaise, pyrexia, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?) on Dec 09, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, weighting 212.3 lb, was diagnosed with gaucher's disease and. Cerezyme dosage: 5000 U, Q4w, Intravenous. Patient was hospitalized.